Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 74Colorectal Neoplasms 41Central Nervous System Neoplasms 37Colonic Neoplasms 36Rectal Neoplasms 34Glioblastoma 23Carcinoma, Non-Small-Cell Lung 21Gliosarcoma 20Stomach Neoplasms 18Lung Neoplasms 18Pancreatic Neoplasms 16Head and Neck Neoplasms 16Sarcoma 14Ovarian Neoplasms 14Squamous Cell Carcinoma of Head and Neck 13Prostatic Neoplasms 12Neoplasm Metastasis 11Melanoma 11Esophageal Neoplasms 11Carcinoma, Ovarian Epithelial 11Carcinoma, Intraductal, Noninfiltrating 11Astrocytoma 11Fallopian Tube Neoplasms 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Breast Carcinoma In Situ 9Liver Neoplasms 8Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8

Interventions

Doxorubicin 9Imatinib Mesylate 6pazopanib 4Ifosfamide 4Radiotherapy 3Gemcitabine 3Docetaxel 3pembrolizumab 2Radiation 2Neoadjuvant Therapy 2Mohs Surgery 2Biopsy 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2selinexor 1saracatinib 1sapanisertib 1ribociclib 1peposertib 1liposomal doxorubicin 1indolepropanol phosphate 1envafolimab 1cixutumumab 1brigimadlin 1avelumab 1X-Rays 1Watchful Waiting 1TTI-621 1Sunitinib 1Specimen Handling 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dermatofibrosarcoma × Chemotherapy, Adjuvant × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡